Detalhe da pesquisa
1.
Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience.
Ann Oncol
; 20(1): 27-33, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18695026
2.
Analysis of structure and patient thanks in scientific meeting oral presentations.
Intern Med J
; 37(5): 351, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17504294
3.
From darkness to light with biomarkers in early clinical trials of cancer drugs.
Clin Pharmacol Ther
; 85(2): 131-3, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19151637